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Abstract 
Heparan sulfate (HS) secreted into the medium of bovine aortic endothelial cell (BAEC) cultures was subjected to chemical and 
enzymatic degradation followed by analysis using gel-filtration and ion-exchange chromatography. Treatment with HNO 2 showed that 
41% of the disaccharides were N-sulfated. Degradation by Heparin lyases I (Hep I) showed that 8-9% of the disaccharides contained 
IdoA(2S) residues. Heparin lyase III (Hep III) degradation produced mainly disaccharides with 67% of the molecules glycosidic linkages 
susceptible to cleavage. Further degradation ofHep III-resistant fragments with Hep I showed that IdoA(2S) residues were predominantly 
positioned centrally within tile repeating GlcNSO3(+ 6S)a 1-4IdoA containing domains. Digestion with a mixture of Heparin lyases I, II 
and III degraded the molectfle almost entirely to disaccharides, with small amounts of tetrasaccharides containing resistant linkages, 
suggesting the presence of 3-0 sulfated GIcNSO 3. Further analysis of the disaccharide products by ion-exchange chromatography and 
comparison with the data from single enzymatic digestions, allowed an estimate of the disaccharide composition to be made. The results 
suggest an ordered arrangement of structural domains; however, variations in the structure of these domains results in a heterogeneous 
population of HS chains. It is suggested that biosynthetic differences in HS structure may act as a regulator of bFGF induced cellular 
responses. 
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1. Introduction 
Proteoglycans (PGs) are a complex family of macro- 
molecules consisting of one or more glycosaminoglycan 
chains attached to a core protein. PGs are widely dis- 
tributed within animal tissues and are generally found in 
the plasma membrane and extracellular matrix (ECM). 
Owing to this location, PGs are well positioned to regulate 
interactions between cells and their microenvironment (for 
reviews see Refs. [1-3]). 
Glycosaminoglycans have been implicated in a wide 
range of biological functions including inhibition of blood 
coagulation [4] interactions with ECM proteins such as 
antithrombin, laminin, collagen and fibronectin [5], cell- 
cell recognition [6] and binding/activation f growth fac- 
Abbreviations: GlcNAc, N-a,=etylglucosamine; GlcNSO3, N-sulfated 
glucosamine; GIcNSO3(6S), N-sulfated glucosamine 6-sulfate; 
GIcNSO3(3S), N-sulfated glucosamine 3-sulfate; GIcNAc(6S), N-acetyl 
glucosamine 6-sulfate; GIcA, glucuronic acid; IdoA, iduronic acid; 
IdoA(2S), iduronic acid 2-sulfate; UA, uronic acid; AGIcA, unsaturated 
glucuronic acid. 
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tors [7]. However, only a few interactions have been 
studied at the structural level, the most notable being the 
heparin-antithrombin a d basic fibroblast growth factor, 
HS complexes. The heparin-antithrombin interaction in- 
volves a pentasaccharide structure containing a 
GIcNSO3(3S) residue which is specifically required for 
high affinity binding [8]. High affinity binding of basic 
fibroblast growth factor to HS requires a sequence of 7 
disaccharides rich in 2-O-sulfated IdoA [9]. The two out- 
standing features of the HS molecule are its high negative 
charge density and heterogeneous composition. It is the 
variability in structure which is thought to give HS its 
wide range of functions [3]. 
This heterogeneity is due to a series of modifications 
which occur after the initial synthesis of the repeating 
GlcNAc-GlcA backbone. The subsequent modification 
pathways proceed in a stepwise manner beginning with the 
removal of up to 50% of the N-acetyl groups with the 
concurrent addition of sulfate [10,1 I]. Subsequent modifi- 
cations involving the epimerisation of GIcA to IdoA fol- 
lowed by 2-O-sulfation of selected IdoA residues occur 
mainly within these N-sulfated regions. Further modifica- 
tions include 6-O-sulfation of GIcNAc/NSO 3 [12,13]. 
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More infrequent modifications include 3-O-sulfation of 
GIcNSO 3 [14-16]. 
These processes lead to the generation of diverse do- 
main structures well suited for interaction with other 
molecules. The domain structure of HS is well established 
both in terms of alternating N-acylated/N-sulfated se- 
quences, and distribution of repeating sequences of IdoA 
residues within the N-sulfated omains [ 17,18]. The aim of 
this study is to further the understanding of the structure of 
endothelial cell derived heparan sulfate (ECHS) by identi- 
fying the composition and size distribution of different 
structural domains. In particular the distribution of 
IdoA(2S) within GIcNSO3-IdoA sequences. Also, the com- 
position of disaccharides within the ECHS molecule is 
estimated. 
2. Materials and methods 
2.1. Materials 
Cell culture media and new-born calf serum were ob- 
tained from Flow Laboratories. DEAE Sephacel, mono Q 
(HR 5/5)  columns and optiphase scintillant from Pharma- 
cia-LKB, o-[1-3H]glucosamine (spec. act. 9.3 mCi/mg) 
was manufactured byAmersham International nd Na 35 SO 4 
(carrier free) by NEN Research Products, Dupont, UK. 
Chondroitin ABC lyase, pronase and trichloroacetic acid 
were all supplied by Sigma Chemical Co. Heparinase 
lyases I, II and III were obtained from Grampian Enzymes. 
All other reagents were purchased from BDH Chemicals 
and were of AnalaR grade. 
2.2. Cell culture and metabolic labelling 
BAECs were isolated and characterised as previously 
described [19] and were used within 15 passages. The cells 
were cultured in Dulbecco's modification of Eagle's 
medium (DMEM) supplemented with 10% (v/v)  new-born 
calf serum, 100 iu/ml penicillin, 100/xg/ml streptomycin 
and 300 /xg/ml glutamine. Cells were seeded at a cell 
density of 5000 cells/cm 2 and 16 h later the medium was 
replaced with DMEM containing 10/zCi /ml  Na35SO4 and 
10 /zCi/ml D-[1-3H]glucosamine. Forty-eight h later the 
medium was removed and the cell layer washed twice with 
phosphate-buffered saline. The medium and washes were 
pooled and centrifuged (100 X g for 10 rain) and stored at 
-20°  C. 
2.3. Preparation of heparan sulfate chains 
PGs in the medium were applied to a DEAE-Sephacel 
column (1 cm X 5 cm) and washed with 0.3 M NaC1 in 20 
mM phosphate buffer (pH 6.8) to remove hyaluronic acid. 
The PGs were resolved with a 200 ml linear gradient of 
0.3 M-1 M NaC1 in 20 mM phosphate buffer (pH 6.8) at a 
flow rate of 10 ml/h, 2-ml fractions were collected and 
0.1 ml aliquots were removed for scintillation counting. 
HS containing fractions were pooled and dialysed against 
distilled water for 24 h and freeze-dried. Small amounts of 
chondroitin/dermatan sulfate (CS/DS) present in the HS 
samples were removed by incubation with 0.5 iu/ml 
chondroitin ABC lyase in 50 mM Tris-HCi, 50 mM NaC1, 
10 /zg/ml BSA (pH 7.8) for 8 h at 37 ° C. Free HS chains 
were produced by incubating samples with 5 mg/ml  
pronase for 18 h at 37°C. CS/DS oligosaccharides and 
peptide fragments were removed by application to a small 
DEAE-sephacel column followed by a wash with 0.3 M 
NaCI in 20 mM phosphate buffer (pH 6.8). Free HS chains 
were removed by step elution with 1 M NaCI in 20 mM 
phosphate buffer (pH 6.8) dialysed against distilled water 
for 48 h and freeze-dried in preparation for further analy- 
sis. 
2.4. Degradation of heparan sulfate chains 
Nitrous acid degradation was performed using the low 
pH method of Shively and Conrad [20]. Freeze-dried sam- 
ples of HS were resuspended in 0.1 ml distilled water and 
deaminative cleavage initiated by addition of 0.4 ml 1 M 
HNO 2 solution. The mixture was incubated for 20 min at 
20 ° C, the reaction being terminated and the solution neu- 
tralized by the addition of 1 M Na2CO 3 using phenol red 
as a pH indicator. Hep I, II and III were used at a 
concentration of 50 miu/ml in 100 mM sodium acetate 0.2 
mM calcium acetate (pH 7.0). Hep I digestion mixtures 
contained 1 mg/ml  heparin as carrier. Samples were 
incubated at 30°C for 48 h. Hep II and III mixtures 
contained 1 mg/ml  bovine kidney HS, samples were 
incubated at 37°C for 48 h. Depolymerization was moni- 
tored by measuring the increase in absorption at 232 nm. 
End points were typically reached after approx. 40 h, after 
which the enzymes were inactivated by heating at 100°C 
for 5 min. 
2.5. Gel chromatography 
Gel chromatography of intact HS and Hep I-digested 
void volume fragments was performed on a sepharose 
CL-6B column (1.0 cm X 120 cm) in 0.5 M NHaHCO 3 
buffer at a flow rate of 4 ml/h. Gel chromatography of HS 
oligosaccharides was performed on a Biogel P-6 column 
(1.5 cm X 120 cm) in 0.5 M NH4HCO 3 buffer at a flow 
rate of 6 ml/h.  In both cases 1-ml fractions were collected 
and small aliquots removed from each fraction for scintil- 
lation counting. Oligosaccharides containing fractions were 
pooled and freeze-dried for further analysis. 
2.6. Ion-exchange chromatography 
Ion-exchange chromatography at low pH allows the 
separation of disaccharides on the basis of their sulfate 
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content, since the charge contribution of uronic acid car- 
boxyl groups at pH 2.0 is negligible. 0.5-ml samples were 
equilibrated in a solution of 10 mM HCI (pH 2.0) and 
loaded onto a mono-Q column (HR 5/5)  followed by a 
4.5-ml wash in the same solution. Disaccharides were 
resolved using a 15-ml linear gradient of 0-1 M NaC1 in 
10 mM HCI (pH 2.0) followed by a 2-ml wash in 10 mM 
HC1 (pH 2.0). A flow rate of 1 ml/min was used and 
0.3-ml fractions were collected. Aliquots were removed 
from each fraction for scintillation counting. 
3. Results 
Dual labelled (3H and 35SO3) labelled HS, was ex- 
tracted from the medium of semi-confluent (proliferating) 
endothelial cells, as described in Section 2. Free HS chains 
were chromatographed using sepharose CL-6B, after treat- 
ment with alkaline borohydride HS chains eluted at a Kav 
of 0.39 approximate molecular weight of 37 kDa [21] (Fig. 
1A). 
Structural features of ECHS were investigated accord- 
ing to the methods of Turnbull and Gallagher [18,22] in 
which 4 specific methods of scission are employed: three 
enzymatic (Heparinase I, H and III) and one chemical (low 
pH HNO 2) treatment. The resulting mixtures of oligo- 
saccharides were resolved by gel filtration and the result- 
ing disaccharide material further analyzed by low pH 
ion-exchange chromatography. 
3.1. Gel filtration 
Hep I cleaves GIcNSO3(+ 6S) c~ 1-4IdoA(2S) residues, 
the general formulae for resistant sequences being 
IdoA(2S)c~ 1 -4[G lcNR(_  6S)c~ 1-4UA]  f l /a  1-4 
GlcNSO3(_ 6S) R being Ac or SO 3. Separation of Hep I 
derived HS oligosaccharides by Biogel P-6 chromatog- 
raphy resulted in the elution profile shown in Fig. 2A. It 
can be seen that only a small number of linkages are 
susceptible. The major products being fragments of size 
> 7 disaccharides and only small amounts of tetrasaccha- 
rides and disaccharides were formed. Further analysis of 
the major peak by gel filtration using Sepharose CL-6B 
showed three peaks with a Kav of 0.55 0.62 and 0.73 with 
corresponding molecular weights of 15, 10 and 5.5 kDa, 
the mean molecular weight of the fragments being approxi- 
mately 10 kDa (Fig. 1B). Assuming the average molecular 
weight of each disaccharide to be 450, a degree of poly- 
merisation (dp) of approximately 40 is obtained. The per- 
centage of susceptible linkages in the intact molecule can 
be determined from the P-6 elution profile by calculating 
the percentage of IdoA(2S) residues in each peak using the 
formulae An/n where n is the number of disaccharide 
repeat units in each oligosaccharide peak and An is the 
percentage total 3H radioactivity in peak n. Taking into 
account that 85% of the radioactivity contained oligo- 
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Fig. I. Separation by Sepharose CL-6B chromatography of intact chains 
and Hep I-resistant oligosaccharides of ECHS. Intact chains (A) and Hep 
I-resistant oligosaccharides (B) (prepared as described in Section 2) were 
treated with alkaline borohydride, applied to a Sepharose CL-6B column 
and eluted with 0.5 M NH4HCO 3 at a flow rate of 4 ml /h.  One-ml 
fractions were collected and small aliquots removed for scintillation 
counting. Molecular weight estimates were based on the calibration 
published by Wasteson [21]. 
saccharides with an average dp of 40, it was calculated that 
approximately 8-9% of the disaccharide units were sus- 
ceptible to Hep L Further analysis of the Hep I elution 
profile showed that 47% of the IdoA(2S) containing disac- 
charides were contained in the disaccharide peak, 12% 
were in the tetrasaccharide p ak and 41% were in the 
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larger oligosaccharide p aks. The disaccharide peak repre- 
sents IdoA(2S) residues which are present in uninterrupted 
sequences, the tetrasaccharide p ak represents IdoA(2S) 
residues eparated by one non-IdoA(2S) containing disac- 
charide and the larger oligosaccharides represent larger 
spacings of IdoA(2S) residues. The data suggest hat the 
small number of GIcNSO3(_ 6S)a 1-4IdoA(2S) disaccha- 
rides present in ECHS are contained together in short 
continuous sequences at a small number of sites within the 
molecule. The disaccharide peak (4.3% of the intact struc- 
ture) was pooled freeze-dried and subjected to low pH 
ion-exchange chromatography. 
Treatment with Hep III yielded an entirely different 
elution profile (Fig. 2B), the major component being disac- 
charides (54% of intact structure) Hep III cleaves linkages 
of the type GlcNR( + 6S)c~ 1-4GlcA, resistant linkages are 
of the type G lcA /31-4[G IcNSOa(+6S)a l -  
4IdoA( + 2S)]n C~ 1-4GlcNR, R being Ac or SO 3. Examina- 
tion of the P-6 profile showed that 67% of the disaccharide 
units were susceptible to Hep III. The general formula for 
resistant linkages shows that the remaining disaccharides 
must contain IdoA or IdoA(2S) and since 8-9% of the 
total disaccharide r sidues are IdoA(2S) (Hep I data) only 
a small proportion of the total IdoA residues (24-27%) are 
2-0 sulfated. Of the 67% of residues usceptible to Hep 
III, 80% were found to be in continuous equences, 7% 
alternating and 13% spaced. Oligosaccharides were pooled 
for further analysis as indicated in Fig. 2b, the disaccharide 
peak was partially resolved into two peaks and were 
pooled into 3 fractions D1, D2 and D3 containing 31.5%, 
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Fig. 2. Separation by Bio-Gel P-6 chromatography of oligosaccharides derived by degradation of ECHS with Hep I, Hep III, HNO 2 and a mixture of Hep 
I, II, III. Samples of HS isolated from the culture medium of endothelial cells were degraded by treatment with Hep I (A): insert shows expansion of 
fractions 50-140, Hep III (B), HNO 2 (C) and a mixture of Hep I, II, III (D) and applied to a Bio-Gel P-6 column (1.5 cm × 120 cm). Oligosaccharides 
were eluted with 0.5 M NH4HCO 3 at a flow rate of 6 ml/h. One-ml fractions were collected and small aliquots removed for scintillation counting ( - -  3H 
radioactivity ....... 35S radioactivity). Oligosaccharide fractions were pooled as indicated and freeze-dried for further analysis. Disaccharide fractions were 
then analyzed for low pH ion-exchange chromatography. Large Hep I-resistant fragments were treated with alkaline borohydride and resolved by 
Sepharose CL-6B chromatography. Hep III-resistant fragments were further degraded by digestion with Hep I and subsequent separation of the resulting 
fragments by Bio-Gel P-6 chromatography. 
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Fig. 3. Low pH ion-exchange chromatography of Hep I derived ECHS 
disaccharides. Disaccharides produced by Hep I digestion of ECHS were 
prepared by Bio-Gel P-6 chromatography (see Fig. 2A) and resolved by 
low pH ion-exchange chromatography. Samples were applied to a mono 
Q HR 5/5 column and disaccharides eluted using a linear gradient of 0 to 
1 M NaCI in 10 mM HCI (pH 2.0) at a flow rate of 1 ml/min. 0.3 ml 
fractions were collected and small aliquots removed for scintillation 
. • • 3~ counting ( - -  - H radioact]wty ....... ~ radioactivity). 
25.5% and 43% of the 3H-radioactivity in the disaccharide 
peak respectively• 
Degradation of ECHS by low pH HNO 2 treatment 
resulted in the elution profile shown in Fig. 2C. The low 
pH deaminative scission method used quantitively releases 
N-sulfate groups with the subsequent cleavage of the 
adjacent hexaminidic bond. Susceptible linkages are of the 
type GlcNSO3( + 6S)a  1-4UA( -F- 2S) resistant linkages be- 
ing UA a/31-4[GlcNAc( 5: 6S)t~ 1-4GlcA],/31-4GlcNSO 3. 
Examination of the 3H radioactivity profile allows the 
percentage of N-sulfated glucosamine residues to be deter- 
mined. Values of 41% for N-sulfation and hence 59% for 
N-acetylation were obtained so that the N-acetyl /N-sulfate 
ratio was 1.44:1. Further analysis showed that 37% of the 
N-sulfate groups were in the disaccharide peak, 34% in the 
tetrasaccharide p ak and 29% in the larger oligosaccharide 
peaks. Analysis of the 35S-radioactive profile revealed that 
92.6% of the label was present in the disaccharide peak, 
the remaining 7.4% being in the tetrasaccharide p ak. In 
order to facilitate the determination of the N:O-sulfate 
ratio the disaccharide peak (which contained free SO 3 
from N-SO 3 breakdown) was pooled into one fraction and 
freeze-dried for further analysis by low pH ion-exchange 
chromatography. 
In order to study further the structure of ECHS, the 
molecule was treated with a mixture of Hep I, Hep II and 
Hep III. Hep II has a much broader substrate specificity 
than that seen for either Hep I or Hep III and has been 
shown to cleave linkages of the type G lcNSO3(+6S)a l -  
4IdoA. The main products of this digestion were seen to be 
disaccharides, the P-6 profile showing the disaccharide 
fraction resolved into two peaks (Fig. 2D). The two peaks 
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Fig. 4. Low pH ion-exchange chromatography of Hep Ill derived ECHS 
disaccharides. Disaccharides produced by Hep HI digestion of ECHS 
were prepared by Bio-Gel P-6 chromatography (see Fig. 2B) and resolved 
by low pH ion-exchange chromatography (see Fig. 3). Pooled fractions 
D1 (A), D2 (B) and D3 (C) ( - -  3H radioactivity ....... 35S radioactivity). 
240 D.A. Pye, S. Kumar / Biochimica et Biophysica Acta 1266 (1995)235-244 
were pooled as indicated into 3 fractions D1, D2 and D3 
consisting of 21%, 11% and 66% of the total 3H radioac- 
tivity respectively. The remaining 2% of the radioactivity 
was contained in the tetrasaccharide p ak. Both disaccha- 
ride peaks were seen to be sulfated and nitrous acid 
treatment of the 3 disaccharide fractions howed that D3 
was completely resistant (result not shown) indicating the 
sulfated component to be GlcNAc(6S)a 1-4GlcA. 
3.2. Ion-exchange chromatography 
Ion-exchange chromatography at pH 2.0 allows the 
separation of disaccharides on the basis of their sulfate 
content, since the charge contribution of uronic acid car- 
boxy groups at pH 2.0 is negligible. Disaccharides are 
separated into non-, mono-, di- and tri-sulfated species, 
also free sulfated (sulfate released by low pH HNO 2 
treatment) is clearly resolved enabling determination f the 
N-/O-sulfate ratio. 
Hep I derived disaccharides were found to consisted 
entirely of tri-sulfated species (Fig. 3), the likely structure 
in the intact molecule being IdoA(2S)al-4GlcNSO3(6S). 
Since the disaccharide peak from Hep I digestion repre- 
sents continuous equences of IdoA(2S) containing disac- 
charides and ion-exchange chromatography does not show 
the presence of di-sulfated species, we conclude that no 
repeating sequences of IdoA(2S)cel-4GIcNSO 3 disaccha- 
rides exist in the molecule. 
Hep III-derived disaccharides were found to consist of 
non- and mono-sulfated species (Fig. 4), the composition 
of the pooled fractions being D1 45% and 55%, D2 78% 
and 22%, D3 98.5% and 1.5% non- and mono-sulfated 
respectively. The likely structures in the intact molecule 
were GIcA/3 1-4GIcNAc (76% of the disaccharide peak) 
and GlcAfl 1-4GlcNAc(6S) or GIcA/3 1-4GlcNSO 3 (24% 
of the disaccharide peak). Treatment with HNO 2 revealed 
that 16% of the mono-sulfated disaccharides were sensi- 
tive, the likely structure in the intact molecule being 
GlcA/3 1-4GlcNSO 3. 
HNO2-derived isaccharides were found to consist of 
non-sulfated, mono-sulfated and di-sulfated species (Fig. 
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Fig. 5. Low pH ion-exchange chromatography of HNO 2 derived ECHS 
disaccharides. Disaccharides produced by HNO 2 digestion of ECHS were 
prepared by Bio-Gel P-6 chromatography (see Fig. 2C) and resolved by 
low pH ion-exchange chromatography (see Fig. 3) ( - -  3H radioactivity, 
...... 35S radioactivity). 
5). The likely structures in the intact molecule were either 
GlcA fl 1-4GlcNSO 3 or IdoA a 1-4GIcNSO 3 (27% of the 
disaccharide peak) IdoA(2S)a I-4GlcNSO 3, GlcA/31- 
4GlcNSO3(6S) or IdoAal-4GlcNSO3(6S) (49% of the 
disaccharide peak) and IdoA(2S)ct 1-4GlcNSO3(6S) (24% 
of the disaccharide peak). The 35S-radioactivity profile 
revealed that free sulfate accounted for 71.5% of the label 
found in the disaccharide peak. Taking into account hat 
7.4% of the 35S-radioactivity s in the tetrasaccharide p ak 
(exclusively O-sulfate) values of 1.96:1 were calculated for 
the N-/O-sulfate ratio, giving a value of 21% for O-sulfa- 
tion. 
Digestion with a mixture of the heparin lyases resulted 
in 98% of the molecule being reduced to disaccharides. 
Separation of the three disaccharide fractions by ion-ex- 
change chromatography resulted in the elution profiles 
Table 1 
Determination of the disaccharide content of ECHS 
Structure Composition % 
N-acetylated disaccharides 
N-sulphated disaccharides 
GlcA/3 I-4GlcNAc 52 
GIcA fl 1-4GIcNAc(6S) 4 
GlcA fl 1-4GlcNSO 3 11 
IdoA a 1-4GlcNSO 3 14 
IdoA a 1-4GlcNSO3(6S) 8 
IdoA(2S) a 1-4GlcNSO 3 5 
IdoA(2S) a 1-4GlcNSO3(6S) 4 
The values obtained are based mainly on the depolymerisation f ECHS with a mixture of Hep I, II, HI and subsequent analysis of the degradation 
products by Bio-Gel P-6 chromatography (Fig. 2D) and low pH ion-exchange chromatography (Fig. 6). However, comparisons were made with data from 
the breakdown of HS with Hep I, Hep HI and HNO 2 (Figs. 2A, 2B, 2C) and low pH ion-exchange chromatography data of the disaccharide products (Figs. 
3-5): The Structures hown represent the disaccharides a they would appear in the intact molecule. 
D.A. Pye, S. Kumar / Biochimica et Biophysica Acta 1266 (1995) 235-244 241 
14 
I= 
1o 
I i  
:t 
I o 
0 
r4 
N 
0 
u 
q4 
u 
, ;  IJ, 
.,q 
° 
0 
.,4 
14 
r~ 
A 
DI* I I  
k lONO-8  
NON- I I  _ ~  
lO 20 ao 40 
TRI -8  
& 
B 
Io 
C 
0 '10 20  JlO 40 60  I~  
18 
16 
14 
- 12 
" 10 
"8  
- I I  
"4  
-2 
700 
! 
O 
,---I 
)4 
O 
4J 
U 
m 
o~ 
E 
> 
0 
Fract ion number 
Fig. 6. Low pH ion-exchange chromatography of ECHS disaccharides 
produced by treatment with a mixture of Hep I, II, III. Disaccharides 
produced by treatment of ECHS with a mixture of Hep I, II, llI were 
prepared by Bio-Gel P-6 chromatography (see Fig. 2D) and resolved by 
low pH ion-exchange chromategraphy (see Fig. 3). Pooled fractions DI 
(A), D2 (B) and D3 (C) ( - -  3H radioactivity ....... 35S radioactivity). 
shown in Fig. 6. Fractiion D1 was resolved into four 
disaccharide peaks composed of non-sulfated 5%, mono- 
sulfated 25%, di-sulfated 52% and tri-sulfated 18%. Frac- 
tion D2 consisted of 3 components: non-sulfated 16%, 
mono-sulfated 64% and di-sulfated 20%. Fraction D3 con- 
sisted mainly of non-sulfated isaccharides (74%), the 
remaining 26% being mono-sulfated. Their likely structure 
in the intact molecule was GIcA/31-4GIcNAc (52% of the 
intact structure), GlcA/3 1-4GlcNAc(6S), GIcA/3 1- 
4GlcNSO 3 and IdoA a 1-4GlcNSO 3 (29% of intact struc- 
ture), IdoA c~ 1-4GIcNSO3(6S) and IdoA(2S)c~ 1-4GIcNSO 3
(13% of the intact structure) and IdoA(2S)c~I- 
4GlcNSO3(6S) (4% of the intact structure). Analysis of 
this data in conjunction with the data from the single 
enzyme digests allows important structural details to be 
determined. Analysis by HNO 2 digestion shows that 22% 
of the 35S label (O-sulfate) is present in the tetrasaccharide 
peak, the resistant linkages being of the type GIcA/3 1- 
4GlcNAc(+ 6S) which indicates approximately 4% of the 
disaccharides are the type GIcA/31-4GlcNAc(6S). Hep III 
digestion indicates that 67% of the disaccharides are of the 
structure GlcNR c~ 1-4GlcA. The remaining 11% must have 
A 
(I) 
(2) 0~]~:~: ]~4~ 
B 
C (2) 
Fig. 7. Proposed arrangement of IdoA(2S)-GIcNSO 3 units within IdoA 
containing domains of ECHS. The structures represented above are 
proposed as a consequence of data obtained from Hep I digestion of Hep 
III resistant fragments (Fig. 7, Table 2). S; SO 3, O; zxGlcA, [3; 
GlcNSO 3, 0 ;  IdoA and [] ; GlcNR where R = Ac or SO 3. 
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the structure GlcAfl 1-4GIcNSO3, leaving the remaining 
14% of mono-sulfated isaccharides to be IdoAfl l-  
4GlcNSO 3. Hep I digestion shows that approximately 9% 
of the disaccharides contain IdoA(2S), since 4% are pre- 
sent in the tri-sulfated fraction of the type IdoA(2S)al- 
4GlcNSO3(6S). The remaining 5% must be of the type 
IdoA(2S)a 1-4GlcNSO 3 and the final 8% of the disulfated 
disaccharides are probably of the type IdoA a 1-4GlcNSO 3. 
These results are summarised in Table 1. 
3.3. Distribution of IdoA(2S) 
Fig. 8. Proposed arrangement of IdoA(2S) within IdoA containing do- 
mains of ECHS. Structures hown are a representation of the data 
obtained by Hep I digestion of Hep III-resistant fragments and separation 
of products by Bio-Gel P-6 chromatography (Table 2). S; SO a, O; 
a GlcA, [] ; GlcNSO 3, 0 ;  IdoA and [] ; GlcNR where R = Ac or SO 3. 
To investigate further the structure of ECHS, the locali- 
sation of IdoA(2S) residues within the molecule was stud- 
ied. From Hep III data it can be seen that IdoA residues 
are present in continuous sequences generating oligo- 
saccharides ranging in size from dp4 to dpl6. These 
fragments were dialysed against distilled water and 
freeze-dried followed by digestion with Hep I. Gel filtra- 
tion of the resulting oligosaccharides generated and analy- 
sis of radioactivity in the peaks yields the data shown in 
Table 2. The resulting profiles are dependent on the distri- 
bution of GlcNSOa(_+6S)ctl-4IdoA(2S) within the Hep 
III-resistant fragments. From Table 2 it can be seen that 
the percentage of Hep I-resistant linkages increases with 
decreasing fragment size, hence the larger the fragment the 
greater the number of 2-0 sulfated IdoA residues. It can 
also be seen that the majority of oligosaccharide products 
are of the size dp4 and @6; few are of the size dp 12-8, 
indicating that IdoA(2S) residues are positioned centrally 
within the Hep III-resistant fragments. Examples of possi- 
ble structures are shown in Fig. 7, for sequences of 7 
disaccharides the preferred arrangement would probably be 
of the type A1, 2, 3 with few sequences of the type A4. 
Similar patterns eem to be preferred for sequences of 6 
and 5 disaccharides with structures of the type B 1, 2 and 
C 1, 2 being most prominent and relatively few of the type 
B3, 4 and C3. Due to the fact that 31% of the disaccha- 
Table 2 
Degradation of Hep III-resistant fragments by Hep I 
Hep III-resistant fragment size 
14 12 10 8 6 4 
Hep I degradation products 14 30.5 
12 33 
10 3.5 7 50 
8 8.5 14 9 69 
6 22 23 24 17 89 
4 23 17 12 8.5 9.5 
2 12.5 6 5 5.5 1.5 
99 
1 
Hep HI-resistant fragments were isolated by degradation of ECHS with 
Hep III followed by Bio-Gel P-6 chromatography (Fig. 2B). Oligosaccha- 
ride (DP 14-4) fractions were pooled separately, dialysed, freeze-dried, 
degraded by Hep I and subjected to Bio-Gel P-6 chromatography. The 
values shown correspond to the percentages of the total 3H-radioactivity 
applied to the column. 
rides are of the general formulae IdoA(_+2S)al- 
4GlcNSO3(+ 6S) and only 8-9% of the disaccharides are 
IdoA(2S)a 1-4GlcNSO3(+ 6S) not all the structures which 
appear to be present (Table 2, Fig. 7) can exist in one HS 
chain, hence many diverse structural HS chains must be 
present. Further information can be extracted from the 
degradation of intact ECHS with Hep I and analysis of the 
disaccharide products; this showed that 4% are in continu- 
ous sequences and all are tri-sulfated, hence there are no 
repeating IdoA(2S)al-4GlcNSO3, therefore the type of 
structures shown in Fig. 8 are preferred. 
4. Discussion 
HS is probably the most widely studied of the GAGs, 
both in structural and functional terms. The initial sulfation 
of GlcNAc to form sulfated domains is the trigger for 
further modifications including epimerization and O-sulfa- 
tion. These processes lead to the generation of a mixture of 
structurally very complex molecules, which poses major 
problems in terms of sequence lucidation. In this study 
we have applied techniques previously used to elucidate 
structural features of fibroblast HS in order to determine 
structural attributes of ECHS. 
Digestion of intact ECHS with the enzyme Hep I and 
analysis of the subsequent products by chromatography 
gives an insight into the distribution of IdoA(2S) residues 
within the molecule. The major degradation products are 
fragments with an average size of 10 kDa, this suggests 
that IdoA(2S) residues are present in four or five sites 
within the molecule in well spaced omains. It can also be 
seen that approximately half of the IdoA(2S) residues (4% 
of total disaccharides) are present in continuous equences 
generating disaccharide products. Ion-exchange chro- 
matography established that these are of the structure 
IdoA(2S)a 1-4GlcNSO3(6S), therefore there are no repeat- 
ing IdoA(2S)al-4GlcNSO 3 residues. Treatment of Hep 
Ill-resistant fragments (i.e., repeating IdoA a 1-4GIcNSO 3
sequences 2-7 disaccharides in length) with Hep I shows 
that IdoA(2S) residues are mainly found in the larger 
sequences (5-7 disaccharides in length), although some 
degradation i the shorter fragments (3-4 disaccharides in
length) is observed. The preferred substrate requirement of
D.A. Pye, S. Kumar / Biochimica et Biophysica Acta 1266 (1995) 235-244 243 
the 2-O-sulfatransferase being long continuous tretches of 
IdoAc~I-4GlcNSO 3 disaccharides. The majority of the 
sequences formed by Hep I digestion of Hep III-resistant 
sequences are 2-3 disaccharides in length, indicating that 
IdoA(2S) residues are placed centrally within the Hep III 
fragments. Only dpl4 fragments, when digested with Hep 
I, showed relatively high amounts of disaccharide products 
representing repeating IdoA(2S) residues. The data also 
reveal that short sequences of unsulfated IdoA residues 
exist in the ECHS molecule. These sequences have been 
detected previously in lung and skin fibroblast HS [22,23] 
but not ECHS [24]. High affinity binding of HS to bFGF 
has been shown to be dependent on the presence of a 
repeating sequence of 5 IdoA(2S) disaccharides [9]. Our 
data suggest hat ECHS contains only short sequences of 
repeating IdoA(2S) residues. If this is the case then ECHS 
may be a good model for ~:he study of the relevant function 
of sequences with low affinity for bFGF i.e., are they 
responsible for functions other than the activation of bFGF 
with respect o its high affinity cell surface receptor? 
Hep III degradation data again demonstrates the domain 
structure of ECHS, IdoA containing disaccharides being 
present in sequences 2-7 disaccharides in length. Hep III 
theoretically generates disaccharides of the structure 
GlcA fl 1-4GlcNSO3(6S), GlcA fl 1-4GlcNSO3, GlcA/3 1- 
4GlcNAc(6S) and GlcAI31-4GlcNAc. However, ion-ex- 
change chromatography data (Fig. 4) demonstrated that no 
disulfated components [GlcA/3 1-4GlcNSO3(6S)] were pre- 
sent as observed previously in fibroblast HS [22]. This 
indicates that different mechanisms control the 6-O-sulfa- 
tion of GlcNAc and GlcNSO 3. 
HNO 2 degradation yields a depolymerization profile 
which is typical of ECHS, the resulting value for N-sulfa- 
tion being 41%. The N-/O-sulfation ratio was calculated 
as 1.98:1; hence, approximately 21% of the disaccharides 
are O-sulfated. These figures are slightly higher than those 
previously reported [25]. ttowever, this may be due to the 
fact that the cells are metabolically abelled whilst prolifer- 
ating. Since Castellot [2611 reported that HS species from 
proliferating and resting ECs had opposing effects on 
smooth muscle cell prolifi~ration, it is possible that struc- 
tural differences exist in the HS species synthesised at 
these times. 
Degradation of ECHS by a mixture of Hep I, II, and III 
produced mainly disaccharide products (98% of total struc- 
ture) the remaining 2% being tetrasaccharides. A recent 
study has characterised three tetrasaccharides that were 
resistant to the actions of Hep II and III with the following 
structures: AGlcA/3 1-4GlcNAc(6S)a 1-4GlcA/3 1- 
4GIcNSO3(3S), AGlcA 131-4GlcNAc(6S)a 1-4GIcA/3 1- 
4GlcNSO3(3S)(6S) and AGlcA/3 1-4GlcNSO3(6S)al- 
4GlcA/3I-4GlcNSO3(3S)(6S) [27]. The authors suggest 
that 3-O-sulfation of the reducing GIcNSO 3 residue con- 
tributes to the resistant nature of these tetrasaccharides. If 
this is the case, then the resistant tetrasaccharides we have 
generated may contain 3-O-sulfated GlcNSO 3. The pres- 
ence of GlcNSO3(3S) has been shown to be a requirement 
for binding of heparin to antithrombin III [8]. Indeed 
GlcNSO3(3S) has been detected previously in ECHS and 
its presence correlated with antithrombin binding [16]. 
Analysis of the disaccharide products produced by the 
action of Hep I, II and III on ECHS and comparisons with 
data derived from the degradation of ECHS using individ- 
ual chemical and enzymatic methods allows an estimation 
of the proportions of the various disaccharide components 
to be made (Table 1). This analysis indicates that 56% of 
the disaccharides are N-acetylated, 42% are N-sulfated in 
agreement with HNO 2 analysis. O-sulfate content was 
approximately 21% as determined by HNO 2 degradation 
(Figs. 2c and 5). Approximately 4% of these are present as 
GIcNAc(6S), 7-8% are present as IdoA(2S), the remaining 
10-1 1% being GIcNSO3(6S). 
Our data suggests an ordered arrangement of structural 
domains within ECHS, with considerable variations possi- 
ble in the structure of these domains. In particular the size 
of IdoA containing domains and distribution of IdoA(2S) 
residues within these sequences. This results in the synthe- 
sis of a heterogeneous population of ECHS chains. It has 
been proposed that different HSPG's can either promote or 
inhibit bFGF-receptor activity [28]. Consequently the bal- 
ance between different species of HSPG's (as a result of 
biosynthetic differences in HS chain structure) could act as 
a regulator of bFGF-induced cellular responses. Further 
studies into structure/functional re ationships of specific 
HS sequences are required as is an insight into regulation 
of HS biosynthesis n order to fully understand any regula- 
tory mechanisms that may be at work in controlling vari- 
ous cellular functions. 
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